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Abstract-Desensitization of N-fonnyl peptide chemoattractant receptors (FPR) in human neutrophils is thought to 
be achieved by lateral segregation of receptors and G proteins within the plane of the plasma membrane resulting in 
an interruption of the signalling cascade. Direct coupling of FPR to membrane skeletal actin appears to be the basis 
of this process~ however, the molecular mechanism is unknown. In this study we investigated the effect of energy 
depletion on formation of FPR-membrane skeleton complexes. In addition the effect of the protein kinase C 
inhibitor stauroporine and the phosphatase inhibitor okadaic acid on coupling of FPR to the membrane skeletonwas 
studied. Human neutrophils were desensitized using the photoreactive agonist N-formy1-met-leu-phe-1ys-N'-
[1251]2(p-azidosalicylamido)ethyl-1,3'-dithiopropionate (fMLFK-[ 125l]ASD) after ATP depletion with NaF or after 
incubation with the respective inhibitors. The interaction of FPR with the membrane skeleton was studied by Sedi-
mentation of the membrane skeleton-associated receptors in sucrose density gradients. Energy depletion of the cells 
markedly inhibited the formation of FPR-membrane skeleton complexes. This does not appear tobe related to inhi-
bition of protein phosphorylation due to ATP depletion because inhibition of protein kinases and phosphatases bad 
no significant effect on coupling of FPR to the membrane skeleton. We conclude, therefore, that coupling of FPR to 
the membrane skeleton is an energy,dependent process which does not appear to require modification of the recep-
tor protein by phosphorylation. 
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skeleton, receptor-G protein coupling. 
INTRODUCTION 
Receptors for N-formyl peptide chemoattractants 
(FPR) are an important component of the body' s 
first line of defence against invading microbes. 
These receptors on human neutrophils transduce 
signals via pertussis toxin-sensitive guanyl 
nucleotide-binding proteins (G-proteins) which 
activate phospholipase C [1, 2]. Typically, recep-
tors of this family exhibit two affinity states for 
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943 
agonists with a high-affinity state representing 
receptor-G protein complexes. Iri the presence of 
GTP this complex is dissociated and the receptors 
are converted to a low-affinity state [3]. In addi-
tion, in desensitized cells a second high affinity 
state of FPR was identified that appears to be 
insensitive to GTP [4-6]. This desensitized recep-
tor state has been called LRX [6] indicating cou-
pling of the ligand-receptor complex to protein( s) 
different from G protein such proteins might be 
cytoskeletal elements. 
Analogous to other G protein-coupled recep-
tors, FPR exhibit the phenomenon of desensitiza-
tion upon prolonged exposure to agonists. Several 
lines of evidence suggest that a new mechanism 
for desensitization of FPR may be operative in 
neutrophils, which is based on a lateral segrega-
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tion of FPR and G proteins into different mem-
brane domains (for review see [7, 8]). This lateral 
segregation could serve as a mechanism to immo-
bilize receptors in a G protein-free · membrane 
domain resulting in an interruption of the sig-
nalling cascade. Recently, it was shown that FPR 
in neutrophils associate with the membrane Skele-
ton upon desensitization [9]. Direct binding of 
FPR to membrane skeletal actin [ 1 0] may be the 
basis for this linkage which could provide for a 
mechanism for FPR immobilization in the plane 
of the plasma membrane [8]. 
It is not clear whether coupling of FPR to the 
membrane skeleton is the event that character-
izes the previously defined state LRX. The most 
striking feature of LRX is its energy-dependent 
formation -[6]. The interaction of other mem-
brane proteins with the membrane skeleton, e.g. 
Na+, K•-ATPase, has also been shown to be 
energy-dependent [11]. Therefore, we studied 
the effect of energy depletion on immobiliza-
tion of FPR to the membrane skeleton. In addi-
tion, the effects of the nonspecific protein 
kinase C inhibitor staurosporine [12] and the 
serine/threonine phosphatase inhibitor okadaic 
acid [13] on FPR-membrane skeleton-coupling 
were tested because ATP depletion might also 
affect desensitization pathways that involve 
phosphorylation. 
MATERIALS AND METHODS 
Materials 
Staurosporine and okadaic acid were purchased 
from Sigma, St Louis, MO. All other materials were 
from sources previously described [9, 14, 15] or highest 
purity available. 
Cells and membranes 
Human neutrophils were prepared as described by 
Parkos et al. [ 14 ]. Desensitized cells were. prepared by 
incubation with the photoreactive agonist jMLFK-
[125l]ASD for 20 min at 15°C as described recently [9]. 
At the end of the incubation period the cell suspension 
was UV -irradiated which Ieads to photoincorporation of 
the Iigand into the receptor protein. Plasma membranes 
of responsive and desensitized neutrophils were pre-
pared by N2 cavitation [9]. 
Inhibitor treatment 
For energy depletion of neutrophils the protocol of 
Sklar et al. [6] was used. In brief, before neutrophils 
were desensitized the cells (I 08 cells/ml) were incu-
bated for 15 or 60 min in Ranks buffer pH 7.4 in the 
presence or absence of 40 mM NaF. After this pretreat-
ment cells were desensitized and membranes were pre-
pared thereafter. The FPR linkage to the inembrane 
skeleton was analysed in sucrose density gradients as 
described {9]. 
Neutrophils were incubated with staurosporine or 
okadaic acid for 10 min at 37oC at a concentration of 
2 J.LM. After this incubation period cells were desensi-
tized with jMLFK-[12~1]ASD at l5°C or immediately 
used for the preparation of plasma membranes (respon-
sive cells). 
Solubilization of membranes and velocity Sedimentation 
ofFPR 
All methods for analysis of receptor coupling were 
performed exactly as described recently [9]. In brief, 
plasma membranes were solubilized in solubilization 
buffer (20 mM HEPES/3 mM MgCI2, pH 7.4 containing 
0.5% Triton X-100). The receptor coupling to the mem-
brane skeleton was monitored by velocity sedimenta-
tion of membrane extracts on detergent-containing 
5-20% sucrose density gradients. The gradients were 
fractionated and aliquots of the individual fractions 
were used for SOS-PAGE. The gels were dried for 
autoradiography and the autoradiograms were analysed 
with a Molecular Dynamics Computing Densitometer 
and the Image Quant software. 
RESULTS AND DISCUSSION 
Neutrophils were incubated with fluoride for 
15 or 60 min at 37oC prior to desensitization with 
the photoaffinity Iigand jMLFK-[1251]ASD. This 
treatment has been shown to decrease the A TP 
Ievel in neutrophils practically to zero [6]. In 
desensitized cells the majority of FPR was found 
in the pellets of sucrose density gradients that 
represent the membrane skeletal pellets [9]. As 
shown in Fig. 1, 75% of the FPR from desensi-
tized neutrophils were found in the membrane 
skeletal pellet while after energy depletion with 
fluoride this portion is reduced to about 30%. 
This result suggests that indeed formation of 
the membrane skeleton·coupled state of FPR is 
energy dependent. Therefore, the desensitized 
receptor state that has been defined as LRX [6) 
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Fig. 1. Effect of energy depletion on FPR-MSK 
coupling. After energy depletion with 40 mM NaF, 
neutrophils were desensitized by incubation with 
jMLFK-[1251]ASD for 20 min at l5°C (for experimen-
tal details see [9]). In desensitized cells (control) 74.9 
± 4,3% of the FPR were found coupled to the mem-
brane skeleton. After fluoride treatment for 15 and 60 
min 30.2 ± 4.6% and 28.9 ± 2.7%, respectively, sedi-
mented to the membrane skeletal pellet in sucrose den-
sity gradients. Values are means ± S.E.M. of four 
experiments. 
might be identical to this FPR population that is 
immobilized to the membrane skeleton [9, 10]. 
The energy-dependent formation of the slowly 
dissociating form of desensitized FPR that is 
insensitive to guanine nucleotides is a peculiarity 
of this receptor and possibly of other chemoattrac-
tant receptors as well. According to our model of 
homologous FPR desensitization this receptor 
form is confined to a G protein-depleted mem-
brane domain [7, 8]. The association of FPR to 
membrane skeletal actin, which is thought to 
serve as the basis for immobilization of receptors 
in the G protein-depleted membrane domain, 
might be the energy-requiring process. 
It is conceivable, however, that after ATP 
depletion the membrane skeleton-coupled state 
cannot be formed because a phosphory lation step 
is involved in immobilization of FPR. The first 
step in rapid desensitization of ß-adrenergic 
receptors, for instance, is phosphorylation of the 
receptor protein [ 16, 17] which then allows for 
binding of ~-arrestin resulting in uncoupling of 
receptor and G protein [18]. Recently, agonist-
dependent phosphorylation of FPR was demon-
strated [19, 20]. Whether such a modification 
initiates binding of FPR to actin, which is 
thought to be. critical for FPR desensitization 
[8-10], is not known. If such an analogy to the 
~-adrenergic receptor and rhodopsin system 
exists one might expect kinase and phosphatase 
inhibitors to affect FPR coupling to the mem-
brane skeleton. In the case of the ß-adrenergic 
receptor a receptor-specific kinase (ß-adrenergic 
receptor kinase, ~ARK) has been shown to 
be responsible for homologous desensitization 
while protein kinase C- and protein kinase A-
mediated phosphorylation appear to be responsi-
ble for heterologous desensitization [21]. 
Staurosporine is an inhibitor with IC50-values for 
protein kinase A and protein kinase C below 
10 nM [12]. However, it does not inhibit ß-
adrenergic receptor kinase at a concentration of 
10 JlM [22]. The recent finding that the FPR is 
phosphorylated mainly by a staurosporine-insen-
sitive kinase [19, 20] suggests that a receptor-
specific kinase might be involved in homologous 
desensitization. Accordingly, staurosporine had 
Table l. Effect of okadaic acid and staurosporine on FPR-MSK coupling 
Responsive cells 
Desensitized cells 
Control 
27.5± 8.4 
66.9 ± 11.3 
Okadaic acid 
31.7 ± 5.7 
54.7 ± 4.4 
Staurosporine 
37.2 ±10.3 
77.2 ± 9.9 
Neutrophils were treated with 2 JJ.M of the respective inhibitor as described in 
Materials and Methods. Values are given as percentage FPR found in the membrane 
skeletal pellet and are means of three to four experiments ± S.E.M. 
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no significant effect of FPR coupling to the 
membrane skeleton (Table l ). Therefore, a role 
for· phosphorylation in FPR-membrane skeleton 
coupling cannot be excluded. 
As another tool used. to study phosphorylation 
as a possible mechanism for coupling of FPR to 
the membrane skeleton, we used the potent ser-
ine/threonine phosphatase inhibitor okadaic acid 
[ 13]. Okadaic acid has profound effects on pro-
tein phosphorylation in neutrophils [23]. If phos-
phorylation were a mechanism that triggers bind-
ing of FPR to the membrane skeleton, inhibition 
of phosphatases might potentiate desensitization. 
However, okadaic acid has been shown to cause a 
sustained formyl peptide-induced respiratory 
hurst in human neutrophils [23]. In our study no 
significant effect of okadaic acid on FPR cou-
pling to the membrane skeleton was detected 
(Table 1). These results soggest that phosphoryla-
tion is not a mechanism to induce coupling of 
FPR to membrane skeletal actin. Recently we 
have demonstrated that coupling of FPR to G 
proteins is not changed in desensitized neu-
trophils [24]. Taken tagether with the results of 
this study this confirms that lateral segregation of 
FPR and G protein is the crucial event for desen-
sitization in human neutrophils that is apparently 
not triggered by receptor phosphorylation. 
Currently it is not clear what molecular mecha-
nism causes the receptor to bind membrane skele-
tal actin instead of G protein after prolonged 
exposure to agonist. In addition to this novel 
mechanism, other mechanisms of desensitization 
that require receptor phosphorylation and subse-
quent binding of an arrestin-like protein in anal-
ogy to the ß-adrenergic receptor or rhodopsin 
also may be operative for FPR. 
In summary, our results are in agreement with 
the hypothesis that physical segregation of FPR 
from G protein within the plane of the plasma 
membrane may be the basis for desensitization 
[8]. We believe that coupling to the membrane 
skeleton is mediated by direct binding of FPR to 
actin [9, 10] and that this membrane skeleton-cou-
. pled state is identical to the previously defined 
desensitized receptor state LRX [6]. This study 
suggests that the energy-dependent formation of 
this state does not require phosphorylation of FPR 
as a molecular determinant for coupling to actin. 
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